FINDING MAY EXPLAIN MANY BRAIN DISORDERS, LEAD TO PREVENTION AND TREATMENT
A new study led by Weill Cornell Medical College scientists shows that the most common genetic form of mental retardation and autism occurs because of a mechanism that shuts off the gene associated with the disease. The findings, published today in Science, also show that a drug that blocks this silencing mechanism can prevent fragile X syndrome — suggesting similar therapy is possible for 20 other diseases that range from mental retardation to multisystem failure.
Fragile X syndrome occurs mostly in boys, causing intellectual disability as well as telltale physical, behavioral and emotional traits. While researchers have known for more than two decades that the culprit behind the disease is an unusual mutation characterized by the excess repetition of a particular segment of the genetic code, they weren’t sure why the presence of a large number of these repetitions — 200 or more — sets the disease process in motion.
Using stem cells from donated human embryos that tested positive for fragile X syndrome, the scientists discovered that early on in fetal development, messenger RNA — a template for protein production — begins sticking itself onto the fragile X syndrome gene’s DNA. This binding appears to gum up the gene, making it inactive and unable to produce a protein crucial to the transmission of signals between brain cells.
“Until 11 weeks of gestation, the fragile X syndrome gene is active — it produces its messenger RNA and protein normally. Then, all of a sudden it turns off, and stays off for the rest of the patient’s lifetime, causing fragile X syndrome. But scientists have not understood why this gene gets shut off,” says senior author Dr. Samie Jaffrey, a professor of pharmacology at Weill Cornell Medical College. “We discovered that the messenger RNA can jam up one strand of the gene’s DNA, shutting down the gene — which was not known before.
“This is new biology — an interaction between the RNA and the DNA of the fragile X syndrome gene causes disease,” Dr. Jaffrey says. “We are coming to understand that RNAs are powerful molecules that can regulate gene expression, but this mechanism is completely novel — and very exciting.”
The malfunction occurs suddenly — before the end of the first trimester in humans and after 50 days in laboratory embryonic stem cells. At that point, the messenger RNA produced by the fragile X syndrome gene makes what the researchers call an RNA-DNA duplex — a particular arrangement of molecules in which the messenger RNA is stuck onto its DNA complement. (DNA produces two complementary strands of the genetic code responsible for human development and function. The four nucleic acids in the genomic code — A, C, G, T — have specific complements. In the case of fragile X syndrome, the repeat sequence in question is CGG. Therefore, RNA binds to its GCC complement on one strand of DNA.)
The RNA-DNA duplex then shuts down production of the fragile X syndrome gene, causing the loss of a protein needed for communication between brain cells. The gene then remains inactive for life. A normal fragile X gene — one with fewer than 200 CGG repeats — stays active in a person without the disorder, and produces the necessary protein. However, the mutant fragile X gene contains more than 200 CGG repeats, resulting in fragile X syndrome. Fragile X occurs in about 1 in 4,000 males and 1 in 8,000 females.
“Because the fragile X syndrome mutation is a repeat sequence, it is very easy for just a small portion of this sequence in the messenger RNA to find a matching repeat sequence on the DNA,” Dr. Jaffrey says. “This is a unique feature of repeat sequences. When there are 200 or more repeats, the RNA-DNA interaction locks into place.”
HOPE FOR TREATMENT — AND OTHER DISORDERS
Dr. Jaffrey and his team, which includes researchers from The Scripps Research Institute in Florida and Albert Einstein College of Medicine in the Bronx, sought to find out why the disease is switched on when the CGG repeat is present in 200 to as many as 1,000 copies.
“Utilizing traditional ways to solve this puzzle has been impossible,” he says. “Human fragile X syndrome genes introduced into mice and cells in the laboratory never turn off, no matter how many CGG repeats the genes have.”
So the scientists turned to human embryonic stem cells. Co-authors Dr. Zev Rosenwaks, director and physician-in-chief of the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine and director of the Stem Cell Derivation Laboratory of Weill Cornell Medical College, and Dr. Nikica Zaninovic, assistant professor of reproductive medicine, generated stem cell lines from donated embryos that tested positive for fragile X syndrome. “These stem cells were critical to the success of this research, because they alone allowed us to mimic what happens to the fragile X gene during embryonic development,” says Dr. Dilek Colak, a postdoctoral scientist in Dr. Jaffrey’s laboratory and the first author of the study.
The stem cells were coaxed to become brain neurons, and at about 50 days, they differentiated in the same way that an embryo’s brain is developing at 11-plus weeks when the fragile X syndrome gene is switched off.
The researchers then used a drug developed by co-author Dr. Matthew Disney of the Scripps Research Institute that binds to CGG in the fragile X gene’s RNA before and after the 50-day switch. Strikingly, the gene never stopped producing its beneficial protein.
That suggests a potential prevention or treatment strategy for fragile X syndrome, Dr. Jaffrey says. “If a pregnant woman is told that her fetus carries the genetic mutation causing fragile X syndrome, we could potentially intervene and give the drug during gestation. This may delay or prevent the silencing of the fragile X gene, which could potentially significantly improve the outcome of these patients,” he says.
The researchers are now looking for similar RNA-DNA duplexes in other trinucleotide repeat diseases, including Huntington’s disease (a degenerative brain disease), myotonic dystrophy 1 and 2 (a multisystem progressive disease), Friedrich’s ataxia (a progressive nervous system disorder), Jacobsen syndrome (an intellectual disorder), and familial amyotrophic lateral sclerosis (a motor neuron disease), among others.
“This completely new mechanism by which RNAs can direct gene silencing may be involved in a lot of other diseases,” Dr. Jaffrey says. “Our hope is that we can find drugs that interfere with this new type of disease process.”
The Latest on: Intellectual Disability and Autism
[google_news title=”” keyword=”Intellectual Disability and Autism” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Intellectual Disability and Autism
- Standards Established To Improve Health Care For Kids With Disabilitieson May 8, 2024 at 7:08 pm
A first-of-its-kind consensus statement is outlining new standards for providing health care to youth with neurodevelopmental disabilities in an effort to overcome persistent inequities in care.
- Josh Shapiro promised to end the wait list for disability services. Now, back it upon May 8, 2024 at 11:17 am
Across Pennsylvania, thousands of families are waiting in limbo, unsure whether their loved ones with intellectual disabilities and autism (ID/A) will ever get the care they need. This month, Gov.
- Milwaukee County could tap $2.5M for housing for residents with autism, other disabilitieson May 8, 2024 at 10:20 am
The money would go to support a $37 million multi-unit development led by nonprofit Communities of Crocus, which aims to provide housing for adults with autism and similar intellectual and ...
- iPad gives nonspeaking woman a voice to advocate for Americans with disabilitieson May 8, 2024 at 9:59 am
A woman with nonspeaking autism got an iPad when she was 18, and through an app on it, is now speaking in schools — and working for the government.
- Gene linked to intellectual disability can regulate learning and memoryon May 8, 2024 at 6:39 am
A gene previously linked to intellectual disability has been found to regulate learning and memory in mice. The gene, called KDM5B has previously been linked to some intellectual disability disorders ...
- Melmark Gala Raises Funds and Honors Champions for Individuals with Disabilitieson May 7, 2024 at 4:00 pm
Melmark, a leading provider of services for individuals with autism, intellectual, and developmental disabilities, hosted its biennial fundraising event, The Dream Maker’s Ball: Melmark Generations, ...
- ‘Breaking a promise’: California deficit could halt raises for disability workerson May 6, 2024 at 2:01 pm
hands-on caregiving to help children and adults with intellectual and developmental disabilities, such as autism, cerebral palsy and epilepsy, remain independent and integrated into their communities.
- Justice Department Warns States Not To Disenfranchise Voters With Disabilitieson May 5, 2024 at 7:51 pm
With the presidential election just months away, the Justice Department is warning that people with disabilities should not be kept from voting due to their guardianship status or for other reasons.
- Acetaminophen in Pregnancy: Risks Intellectual Disability in Childrenon April 29, 2024 at 4:43 am
Extensive study shows no risk of neurodevelopmental disorders in children when acetaminophen is used by pregnant women; however, caution needed with painkillers.
- Support A Sport provides an inclusive space where kids with disabilities can get their game onon April 28, 2024 at 3:35 pm
That eventually inspired Support A Sport, an inclusive space for children with disabilities to get on the field. They now offer a variety of sporting activities based on the season. The programs are ...
via Bing News